retatrutide expanded access program New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats retatrutide expanded access program eli

48 Given the structural absence of GLP-1R identified in human liver tissue, this appears to be a compromise

Love Employee stock.adobe.com News Study finds faster regain than ending diet programmes GLP-1 discontinuation: weight-loss drugs work until you stop Research sounds a cautionary note for short-term use without a more comprehensive approach to weight management People tend to regain weight rapidly after stopping weight-loss drugs - and faster than after ending behavioural weight loss programmes - according to a new systematic review and meta-analysis from researchers in Oxford's Nuffield Department of Primary Care Health Sciences, published in The BMJ

Quicker weight loss can backfire by lowering the rate at which your body burns calories, promoting muscle loss and possibly leaving you deficient in certain key nutrients

Treatment evolves as progress is made, ensuring that each patient continues moving toward their goals at a safe, sustainable pace

The peptide does not interact with hormonal pathways, making it one of the few compounds where sex-based dose adjustment is unnecessary